Hersintuzumab (Anti-ERBB2 / HER2 / CD340)

Hersintuzumab (Anti-ERBB2 / HER2 / CD340) is a humanized monoclonal antibody that targets human epidermal growth factor receptor 2 (HER2), extracellular domains I–II, with antitumor activity in ovarian cancer. MW: 144.26 KD.

• Supplier: Selleck Chemicals
• Product #: A2898
• Sku #: A2898-1mg*25